Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy
- 31 October 1989
- journal article
- review article
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 19 (4) , 332-339
- https://doi.org/10.1016/s0001-2998(89)80025-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Experimental model systems for antibody targeting and radioimmunodetectionPublished by Springer Nature ,1990
- Innovations in Monoclonal Antibody Tumor TargetingPublished by American Medical Association (AMA) ,1989
- Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.Proceedings of the National Academy of Sciences, 1988
- Peritoneal carcinomatosis: imaging with intraperitoneal injection of I-131-labeled B72.3 monoclonal antibody.Radiology, 1988
- Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.Journal of Clinical Oncology, 1987
- Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.Radiology, 1987
- Current status of cancer imaging with radiolabeled antibodiesZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Variables affecting the tumor localization of131 I-antiferritin in experimental hepatomaAmerican Journal of Clinical Oncology, 1984
- Clinical Radioimmunodetection of Cancer with Radioactive Antibodies to Human Chorionic GonadotropinScience, 1980
- Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External PhotoscanningNew England Journal of Medicine, 1978